Skip to main content
An official website of the United States government

acitretin

An orally-active metabolite of the synthetic aromatic retinoic acid agent etretinate with potential antineoplastic, chemopreventive, anti-psoratic, and embryotoxic properties. Acitretin activates nuclear retinoic acid receptors (RAR), resulting in induction of cell differentiation, inhibition of cell proliferation, and inhibition of tissue infiltration by inflammatory cells. This agent may also inhibit tumor angiogenesis.
Synonym:Trimethylmethoxyphenyl-retinoic acid
US brand name:Etretin
Soriatane
Foreign brand name:Neotigason
Code name:Ro 10-1670
Ro-10-1670
Chemical structure:(All-E)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic Acid
Search NCI's Drug Dictionary